Crystalys Therapeutics said on Tuesday it has emerged from stealth mode with a funding round of $205 million to help finance ...

The biotech is starting up with partial rights to a drug that’s approved in multiple Asian countries and its executives see ...

Crystalys Therapeutics Inc., ('Crystalys' or 'the Company'), a clinical-stage biopharmaceutical company, is announcing its launch with a $205 million Series A financing to support its mission of ...

A groundbreaking study reveals genetics—not diet or alcohol—are the primary cause of gout, challenging long-held myths and ...

WASHINGTON, DC — Use of sodium-glucose cotransporter-2 inhibitors (SGLT2i) reduced the need for urate-lowering therapy (ULT) and gout flare therapies in people who had both type 2 diabetes (T2D) and ...

The gout market is poised for steady growth, driven by the rising prevalence of the disease, increasing awareness, and the launch of novel therapies such as AR-882, Epaminurad, XNW3009, XRx-026, ...

What is Gout? Gout is a type of arthritis that can cause severe pain and discomfort, often at night. Gout is caused by the ...

Atom Therapeutics has announced enrollment of the first patient in a Phase II trial (NCT07145229) for ABP-745, a novel ...

Dietary lignans found in whole grain cold cereals and oatmeal may reduce the risk for gout, according to findings published ...

Credit: Getty Images The intense pain and inflammation caused by gout may pose physical limitations that affect the mental and emotional health of patients living with the disease. Gout is an ...